| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/13/2006 | US20060154913 Drugs for treatment of respiratory syncytial virus and salt formation |
| 07/13/2006 | US20060154896 Phosphorylated dextrans |
| 07/13/2006 | US20060154892 Procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis |
| 07/13/2006 | US20060154878 for treating bacterial infections; intermediates for the synthesis of other macrolide antibiotics |
| 07/13/2006 | US20060154871 Peptides |
| 07/13/2006 | US20060153893 Therapeutic composition for bone infectious disease |
| 07/13/2006 | US20060153879 Streptococcal C5a peptidase vaccine |
| 07/13/2006 | US20060153875 Novel brachyspira hyodyseteriae vaccine |
| 07/13/2006 | US20060153873 Smallpox vaccine |
| 07/13/2006 | US20060153865 Antigenic peptides |
| 07/13/2006 | US20060153864 truncated papillomavirus L1 protein consisting of an amino acid sequence having one or more carboxy terminal amino acid residues deleted from a full length L1 amino acid sequence, and amino acid residues from a second protein replacing deleted amino acid residues in the truncated L1 protein. |
| 07/13/2006 | US20060153858 Drug delivery of a liquid comprising an antigen such as tumor-associated antigen directly to an area of high lymphatic drainage or a lymphatic system of the mammal to induce an antigen-specific Cytotoxic T lymphocyte (CTL) response; sustained release |
| 07/13/2006 | US20060153839 Production of bispecific molecules using polyethylene glycol linkers |
| 07/13/2006 | US20060153833 Anti hepatitis C virus antibody and uses thereof |
| 07/13/2006 | US20060153779 Rapidly producing peak plasma concentration; condensation aerosol containing ephedrine and/or fenfluramine; vaporization without degradation |
| 07/13/2006 | US20060153770 Method of treating tumors |
| 07/13/2006 | US20060151899 Process for producing drug ultramicroparticle and apparatus therefor |
| 07/13/2006 | US20060151574 Formulations useful against hepatitis C virus infections |
| 07/13/2006 | CA2594091A1 Selected benzofuran derivatives |
| 07/13/2006 | CA2592888A1 Pharmaceutically active antiviral peptides |
| 07/13/2006 | CA2592883A1 Treatment of hcv disorders |
| 07/13/2006 | CA2591138A1 Antibodies against antigen presenting cells and uses thereof |
| 07/13/2006 | CA2588026A1 Methods and compositions for rna interference |
| 07/13/2006 | CA2587310A1 Tripeptide and tetrapeptide sulfones |
| 07/13/2006 | CA2587284A1 Tripeptide and tetrapeptide thioethers |
| 07/13/2006 | CA2584425A1 1, 5, 6-substituted-2-oxo-3-cyano-1, 6a-diaza-tetrahydro-fluoranthenes |
| 07/12/2006 | EP1679377A1 Feline immunodeficiency virus vaccine |
| 07/12/2006 | EP1679305A1 9-Substituted minocycline compounds |
| 07/12/2006 | EP1679076A1 Compounds useful in the treatment of HIV |
| 07/12/2006 | EP1679065A1 Controlled release compositions for interferon based on PEGT/PBT block copolymers |
| 07/12/2006 | EP1679064A2 Pharmaceutical compositions containing rapamycin derivatives |
| 07/12/2006 | EP1678185A1 2,3-dihydro-6-nitroimidazo [2,1-b] oxazole compounds for the treatment of tuberculosis |
| 07/12/2006 | EP1678133A1 Sequence selective pyrrole and imidazole polyamide metallocomplexes |
| 07/12/2006 | EP1677811A1 Medicament on the basis of honey, preparation and use thereof |
| 07/12/2006 | EP1677785A1 Benzimidazole derivatives and use thereof as peptide deformylase inhibitors |
| 07/12/2006 | EP1677781A1 Salts of pharmacologically active compounds |
| 07/12/2006 | EP1441718B1 Use of carbinols for the treatment of neuropathic dysfunction |
| 07/12/2006 | EP1427732B1 Spirocyclic-6,7-dihydro-5h-pyrazolo 1,2-a|pyrazol-1-ones which control inflammatory cytokines |
| 07/12/2006 | EP1427730B1 Novel dihydropteridinones, method for producing the same and the use thereof as medicaments |
| 07/12/2006 | EP1419118B1 Antimicrobial, anti-inflammatory, wound-healing glass powder and use thereof |
| 07/12/2006 | EP1392311B1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 07/12/2006 | EP1311286B1 Treatment of hepatitis c with thymosin and pegylated interferon |
| 07/12/2006 | EP1254253B1 Single stranded oligonucleotides, probes, primers and method for detecting spirochetes |
| 07/12/2006 | EP1025846B1 Aqueous liquid preparations |
| 07/12/2006 | CN1802354A Tetrahydrocarbazole derivatives and their pharmaceutical use |
| 07/12/2006 | CN1802179A Compositions containing piperacillin and tazobactam useful for injection |
| 07/12/2006 | CN1802154A Pyridine N-oxides as antiviral agents |
| 07/12/2006 | CN1800213A Peptides |
| 07/12/2006 | CN1800210A Compounds for treatment of infectious and immune system disorders and methods for their use |
| 07/12/2006 | CN1800198A Method for preparing macrolides half-synthesized antibiotics telithromycin |
| 07/12/2006 | CN1800167A Anaerobe resistant compound |
| 07/12/2006 | CN1799630A Chitosan-immune RNA composite formulation and preparation method thereof |
| 07/12/2006 | CN1799626A Recombined human interferon-gamma liposome gel and its application in treatment of condyloma acuminatum |
| 07/12/2006 | CN1799612A Novel drug administering route of 'Qu Gan Re' injection, its preparation process and novel indications |
| 07/12/2006 | CN1799586A Cold treating capsule and its preparation method |
| 07/12/2006 | CN1799575A Chinese medicinal dispersible tablet, its preparation process and quality control method |
| 07/12/2006 | CN1799569A Chinese medicinal soft capsule, its preparation process and quality control method |
| 07/12/2006 | CN1799557A Chinese medicinal gel formulation, its preparation process and quality control method |
| 07/12/2006 | CN1799550A Highly efficient formulation of hepsera and preparation method thereof |
| 07/12/2006 | CN1799537A Preparation method and clinical application of acetylcysteine powdered injection and acetylcysteine infusion |
| 07/12/2006 | CN1263854C Neisserial antigens |
| 07/12/2006 | CN1263848C Artificially recombinant H9N2 hypotype influenza virus and its uses |
| 07/12/2006 | CN1263768C New taraxerol derivative and its preparation and use |
| 07/12/2006 | CN1263762C Desugar and deaminosugar FR-008 derived polyketone antibiotics |
| 07/12/2006 | CN1263755C Pyrazolopyridine derivatives as selective COX-2 inhibitors |
| 07/12/2006 | CN1263731C Novel immunotherapeutic agents and their use in production of cytokine levels |
| 07/12/2006 | CN1263511C Live recombined vaccines injected with adjuvant |
| 07/12/2006 | CN1263510C Polysaccharide protein conjugate or oligosaccharide-protein conjugate, preparation method and application thereof |
| 07/12/2006 | CN1263509C Novel compositions |
| 07/12/2006 | CN1263508C Stabilizers for live vaccines |
| 07/12/2006 | CN1263506C Application of laevorotation carnosine in preparation of medication for assistant treatment of hepatitis and healthy foods |
| 07/12/2006 | CN1263491C Capsule for treating myocarditis of coxsackie B virus type, and its preparation method |
| 07/12/2006 | CN1263480C Composition of Chinese traditional medicine for curing common cold and preparation method |
| 07/12/2006 | CN1263467C Pharmaceutical compositions containing lactobacilli for treatment of vaginal infections |
| 07/12/2006 | CN1263458C Nystatin or nystatin lipid composition and its preparation method |
| 07/12/2006 | CN1263452C Powder injection of lactatelevo-ofloxacin and its preparation |
| 07/12/2006 | CN1263449C Buccal tablet for treating oral anaerobe infection disease and its manufacturing method |
| 07/11/2006 | US7074925 N-substituted derivatives of 5-oxyiminobarbituric acid |
| 07/11/2006 | US7074896 Gene expression of nucleic acid in prokaryotic cells; homogeneity, purity; immobilization; separation of antibodies by chromatography |
| 07/11/2006 | US7074894 Antigen composition against mycoplasma |
| 07/11/2006 | US7074802 analgesics; antipyretics; antiinflammatory agents; antiarthritic agents |
| 07/11/2006 | US7074801 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof |
| 07/11/2006 | US7074799 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity |
| 07/11/2006 | US7074794 pyrrolo-2yl-carbonyl-amino compounds; dipeptidyl peptidase inhibitor |
| 07/11/2006 | US7074793 KInase inhibitor; Alzheimer's disease; central nervous system disorders; antiinflamamtory agents; skin disorders; osteoporosis; atherosclerosis; restenosis; thrombosis; antidiabetic agents; viricides; fungicides |
| 07/11/2006 | US7074784 Medicaments against viral diseases |
| 07/11/2006 | US7074782 Administering to a patient suffering from caspase mediated diseses, an effective amount of a mono,bi or tri-heterocyclic ring containing nitrogen atom attached to ester or thioester to form carbamate group, as caspase inhibitor |
| 07/11/2006 | US7074776 Exposing bacterium to heterocyclic comound for controlling growth |
| 07/11/2006 | US7074770 Administering to a mammal a vector or nucleotide sequence which code an antigenic peptide; together with Schiff base |
| 07/11/2006 | US7074766 antiinflammatory agents; autoimmune diseases; thrombosis; viricides; blood disorders; antitumor agents |
| 07/11/2006 | US7074760 Bactericides; peptide antibiotics |
| 07/11/2006 | US7074620 Controlling protein levels in eucaryotic organisms |
| 07/11/2006 | US7074601 Nucleozymes |
| 07/11/2006 | US7074554 Methods for detecting NEBR1 expression in a biological sample by contacting a sample with the labeled antibody; inhibits HIV replication in host cells |
| 07/11/2006 | US7074431 Expanding the homogeneous solution by exposing it to a change in pressure under conditions such that the solution or homogeneous dispersion does not boil |
| 07/11/2006 | US7074417 At least three delayed release dosages forms, each of which has a different release profile, with the Cmax for the antiviral product being reached in less than about twelve hours. |
| 07/11/2006 | US7074414 Cold-adapted equine influenza viruses |
| 07/11/2006 | US7074411 α-β C4BP-type recombinant heteromultimeric proteins |
| 07/11/2006 | US7074408 Use of integrin antagonists to inhibit angiogenesis |
| 07/11/2006 | US7074403 Immunotherapy of autoimmune disorders using antibodies which target B-cells |